Last Updated: November 8, 2026

Details for Patent: 11,839,656

Name: Drug Patent Intelligence for US Patent 11839656
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent 11,839,656 protect, and when does it expire?

Patent 11,839,656 protects BRYHALI and DUOBRII and is included in two NDAs.

This patent has twenty-six patent family members in nineteen countries.

Summary for Patent: 11,839,656

Title:	Pharmaceutical formulations containing corticosteroids for topical administration
Abstract:	Pharmaceutical compositions for topical application to skin are provided. In some embodiments, the pharmaceutical compositions comprise a corticosteroid and further comprise a liquid oil component comprising one or more dicarboxylic acid esters and/or monocarboxylic acid esters.
Inventor(s):	Arturo Angel, Gordon Dow
Assignee:	Bausch Health Ireland Ltd
Application Number:	US17/993,806
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Delivery;

Drugs Protected by US Patent 11,839,656

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch	BRYHALI	halobetasol propionate	LOTION;TOPICAL	209355-001	Nov 6, 2018		RX	Yes	Yes	11,839,656	⤷ Start Trial				TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS	⤷ Start Trial
Bausch	DUOBRII	halobetasol propionate; tazarotene	LOTION;TOPICAL	209354-001	Apr 25, 2019	AB	RX	Yes	Yes	11,839,656	⤷ Start Trial				TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,839,656

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011345240	⤷ Start Trial
Brazil	112013012476	⤷ Start Trial
Canada	2817524	⤷ Start Trial
Canada	3055328	⤷ Start Trial
China	103228281	⤷ Start Trial
European Patent Office	2643002	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.